Search for: "Eli Lilly " Results 1581 - 1600 of 2,131
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 May 2017, 12:59 pm
Here's my checklist|Fujifilm v AbbVie: practice, procedure and policy analysis|Overturning a trade mark opposition decision - Part 2 - SOULUXE - likelihood of confusion|Overturning a trade mark opposition decision - Part 1 - IWATCH, descriptive goods and acquired distinctivenessNever Too Late 143 [week ending on Sunday 9 April] |French court rules that resale right royalty must be only paid by sellers I Tune in LIVE for tomorrow's Eli Lilly v Actavis Supreme… [read post]
19 Jan 2016, 2:12 am
Never too late 78  [week ending on Sunday 27 December] – Zer-sum claim and lookalike products | 2015 Copyright Awards | Santa Claus and Section 52 | Jani writes on Dallas Buyers Club LLC v iiNet Limited | IP Hairballs |  Actavis v Eli Lilly | Power outage at USPTO | Santa's GC resigns | Pet rock and IP.Never too late 77 [week ending on Sunday 20 December] – GC on 5-stripe shoe mark | EPO BoA… [read post]
4 Jun 2018, 3:02 am
Image credits: Sleepwalking - GIPHYAmsterdam - Shovy Rahman PREVIOUSLY ON NEVER TOO LATENever Too Late 194 [weeks ending 13th and 20th May] Important amendments under Mexican law regarding patents, utility models and industrial designs | Decoding the Scope of Patent Protection: Singapore after Eli Lilly v. [read post]
25 May 2015, 1:28 am
In Human Genome Sciences Inc. v Eli Lilly and Company [2011] UKSC 51 the Supreme Court reversed the findings of the High Court and Court of Appeal. [read post]
24 Jan 2015, 8:19 pm
The answer is not clear-cut but as a general rule the post-filing data can only be ‘confirmatory’ of disclosure in the specification.As an aside, it is worth mentioning Human Genome Sciences v Eli Lilly where the main issue was how much data is required in the specification to support therapeutic use of an antibody to a new protein (see Katpost here).Why is it important to claim broadly in biotech? [read post]
30 Apr 2017, 4:30 am
| Tune in LIVE for tomorrow's Eli Lilly v Actavis Supreme Court showdown | French court rules that resale right royalty must be only paid by sellersNever Too Late 142 [week ending on Sunday 2 April] | Conference report: Online platforms and intermediaries in copyright law | Fun with Fujifilm Declarations! [read post]
12 Feb 2018, 2:33 am
 EssaysWas the Supreme Court right in Actavis v Eli Lilly to introduce a doctrine of equivalents when determining infringement of patents in the UK? [read post]
30 Apr 2019, 5:29 am
This focused on the three-step test of the Eli Lilly v Actavis UK Supreme Court decision and the subsequent UK cases applying that  test. [read post]
8 Mar 2023, 2:51 pm by Lawrence B. Ebert
Eli Lilly & Co., 598 F.3d 1336, 1350−52 (Fed. [read post]
17 Oct 2017, 6:09 pm
The panel members were Mattias Zigann, the presiding judge of the Munich Regional Court, Philip Kerr of Allens Linklaters and Larry Welch, the Senior Director, and Assistant General Patent Counsel at Eli Lilly and Company.Mr Ludwig explained that the question of what relief was appropriate had been highlighted by the very recent decision of the United States Court of Appeals for the Federal Circuit in AMGEN INC & ors v. [read post]
18 Oct 2017, 5:33 pm
 The second panelist, Jonathon Anderson, patent counsel with Eli Lilly, then addressed the session on some specific IP considerations for digital health businesses, considered particularly from the perspective of an established pharmaceutical/medical devices company. [read post]
24 Oct 2017, 8:33 am
In this guest post, she shares her thoughts and updates us on the related developments.Pemetrexed pops up in MilanGuest Kat Eibhlin gives takes us through the recent decision handed down by the Court of Milan which forms part of the long running multi-jurisdictional battle concerning Eli Lilly's patent protecting its pemetrexed (Alimta) product.Medical data in a twist - Technomed v BluecrestGuest Kat Rosie demystifies database rights with the recent decision of Technomed v… [read post]
10 Jun 2014, 7:44 pm
 In this post, guest contributor Paul England (Taylor Wessing LLP) explains the legal issues and their consequences:UKIPO -- a 'court' for the purposes of the Brussels I Regulation Some courts look like this ...With Actavis v Eli Lilly [noted on the IPKat here] still fresh in our minds, and amendments to the Brussels I Regulation (recast) progressing through the European Parliament in preparation for the Unified Patent Court, jurisdictional matters are a hot… [read post]
8 May 2017, 10:17 am
Here's my checklist|Fujifilm v AbbVie: practice, procedure and policy analysis|Overturning a trade mark opposition decision - Part 2 - SOULUXE - likelihood of confusion|Overturning a trade mark opposition decision - Part 1 - IWATCH, descriptive goods and acquired distinctivenessNever Too Late 143 [week ending on Sunday 9 April] |French court rules that resale right royalty must be only paid by sellers I Tune in LIVE for tomorrow's Eli Lilly v Actavis Supreme Court… [read post]